Miriam Koopman.

We did not observe a significant correlation between KRAS mutation status or EGFR expression and the incidence of cetuximab-related adverse cutaneous results . As compared...

Held 24 to 26 October 2014 in London.

The survey was conducted as part of the pre-conference research created for 7th Annual Development IP Strategies for Crystalline Forms, held 24 to 26 October...